Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 4
1994 22
1995 39
1996 37
1997 46
1998 37
1999 33
2000 45
2001 47
2002 43
2003 48
2004 40
2005 54
2006 57
2007 55
2008 61
2009 58
2010 51
2011 63
2012 57
2013 55
2014 41
2015 37
2016 36
2017 33
2018 23
2019 20
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

1,051 results
Results by year
Filters applied: . Clear all
Page 1
Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K. Weiskopf K. Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10. Eur J Cancer. 2017. PMID: 28286286 Review.
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.
Topper MJ, Vaz M, Chiappinelli KB, DeStefano Shields CE, Niknafs N, Yen RC, Wenzel A, Hicks J, Ballew M, Stone M, Tran PT, Zahnow CA, Hellmann MD, Anagnostou V, Strissel PL, Strick R, Velculescu VE, Baylin SB. Topper MJ, et al. Cell. 2017 Nov 30;171(6):1284-1300.e21. doi: 10.1016/j.cell.2017.10.022. Cell. 2017. PMID: 29195073 Free PMC article.
Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.
Ostrov DA, Alkanani A, McDaniel KA, Case S, Baschal EE, Pyle L, Ellis S, Pöllinger B, Seidl KJ, Shah VN, Garg SK, Atkinson MA, Gottlieb PA, Michels AW. Ostrov DA, et al. J Clin Invest. 2018 May 1;128(5):1888-1902. doi: 10.1172/JCI97739. Epub 2018 Apr 3. J Clin Invest. 2018. PMID: 29438107 Free PMC article.
1,051 results
Jump to page
Feedback